EMG in COPD - Factor Analysis
Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Mar 22, 2016
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
Introduction Patients admitted to hospital with acute exacerbations of COPD are at risk of significant in-hospital morbidity and mortality. Current markers of treatment success involve the integration of basic physiological variables (respiratory rate, heart rate, oxygen saturations), clinical examination and patient reported symptoms changes. Whilst the use of these physiological parameters are gold standard there remains concern that patient deterioration is often not detected and escalated effectively. This has led to the development and implementation of a range of clinical physiologica...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD (as defined by GOLD criteria
- • Acute exacerbation of COPD necessitating hospital admission
- • Expected to remain an inpatient for ≥ 24 hours
- • Able to give informed consent to participation in the study
- Exclusion Criteria:
- • Decompensated respiratory failure (pH \< 7.35)
- • Significant physical, social or psychiatric factors that would prevent compliance with trial protocol
- • Aged \< 35 years or aged \> 85 years
- • Pregnancy
- • BMI \> 30kg/m2
- • Presence of another acute pathology (such as pulmonary embolism or pulmonary oedema) to explain the acute presentation
About Guy's And St Thomas' Nhs Foundation Trust
Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Nick Hart
Principal Investigator
Guy's and St Thomas' NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials